Literature DB >> 15090714

A case of mitral stenosis complicated with seronegative Brucella endocarditis.

Turhan Yavuz1, Mehmet Ozaydin, Vildan Ulusan, Ahmet Ocal, Erdogan Ibrisim, Ali Kutsal.   

Abstract

Brucellosis is a multisystemic disease. The most common cause of death from the disease is endocarditis. The aortic valve is most commonly affected. The disease rarely involves the mitral valve. A 30 year-old woman presented with complaints of chills and fever up to 38 degrees C at night, fatigue, palpitations, and dyspnea for the previous 3 weeks. Cardiac auscultation revealed a diastolic murmur in the mitral area. Her temperature was 38.3 degrees C. On echocardiographic examination, the mitral valve area was 0.62 cm (2) and an isoechoic mass thought to be a vegetation was detected on the anterior mitral leaflet. A diagnosis of infective endocarditis was made and vancomycin administration was commenced. Brucella melitensis was isolated in all three blood samples, however, the patient remained seronegative with Brucella agglutination titers of up to 1/160. The antibiotic therapy was then shifted to doxycycline (200 mg/day), rifampicin (600 mg/day), and ciprofloxacin (1000 mg/day). After 30 days of treatment, surgery was performed for the severely stenotic mitral valve and to remove the vegetation. The operation was successful. The postoperative period was uneventful. On the follow-up she had no complaints. In cases with Brucella endocarditis, after diagnosis, antibiotic therapy must be started immediately and when the clinical condition improves, surgical intervention should be performed when indicated.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15090714     DOI: 10.1536/jhj.45.353

Source DB:  PubMed          Journal:  Jpn Heart J        ISSN: 0021-4868


  6 in total

Review 1.  Quinolones for treatment of human brucellosis: critical review of the evidence from microbiological and clinical studies.

Authors:  Matthew E Falagas; Ioannis A Bliziotis
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

2.  Tissue culture positive prosthetic aortic valve Brucella endocarditis.

Authors:  M I Tasbakan; T Yamazhan; B Arda; H Pullukcu; O R Sipahi; C Buke; S Ulusoy
Journal:  Ir J Med Sci       Date:  2006 Apr-Jun       Impact factor: 1.568

3.  Brucella endocarditis - a series of five case reports.

Authors:  I Tammi Raju; Rachana Solanki; A N Patnaik; R C Barik; N R Kumari; A S Gulati
Journal:  Indian Heart J       Date:  2013-01-02

4.  Brucellosis of the lung: case report and review of the literature.

Authors:  Dirk Theegarten; Sven Albrecht; Martin Tötsch; Helmut Teschler; Heinrich Neubauer; Sascha Al Dahouk
Journal:  Virchows Arch       Date:  2007-10-20       Impact factor: 4.064

Review 5.  Medical versus medical and surgical treatment for brucella endocarditis.

Authors:  Maryam Keshtkar-Jahromi; Seyed-Mostafa Razavi; Sharareh Gholamin; Marzieh Keshtkar-Jahromi; Mian Hossain; Mohammad M Sajadi
Journal:  Ann Thorac Surg       Date:  2012-10-26       Impact factor: 4.330

Review 6.  Brucella endocarditis in prosthetic valves.

Authors:  Snjezana Mehanic; Velida Mulabdic; Rusmir Baljic; Meliha Hadzovic-Cengic; Fikret Pinjo; Vesna Hadziosmanovic; Jasna Topalovic
Journal:  Mater Sociomed       Date:  2012
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.